Zajkowska Monika, Dulewicz Maciej, Kulczyńska-Przybik Agnieszka, Safiejko Kamil, Juchimiuk Marcin, Konopko Marzena, Kozłowski Leszek, Mroczko Barbara
Department of Neurodegeneration Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.
Department of Oncological Surgery with Specialized Cancer Treatment Units, Maria Sklodowska-Curie Oncology Center, 15-027 Bialystok, Poland.
J Clin Med. 2022 Mar 24;11(7):1794. doi: 10.3390/jcm11071794.
Colorectal cancer (CRC) is one of the most frequently diagnosed neoplasms. Despite the advances in diagnostic tools and treatments, the number of CRC cases is increasing. Therefore, it is vital to search for new parameters that could be useful in its diagnosis. Thus, we wanted to assess the usefulness of selected CC chemokines (CCL2, CCL4, and CCL15) in CRC. The study included 115 subjects (75 CRC patients and 40 healthy volunteers). The serum concentrations of all parameters were measured using a multiplexing method (Luminex). The CRP levels were determined by immunoturbidimetry, and the classical tumor markers (CEA and CA 19-9) were measured using CMIA (chemiluminescent microparticle immunoassay). The concentrations of all parameters were higher in the CRC group when compared to the healthy controls. The diagnostic sensitivity, specificity, positive and negative predictive value, and area under the ROC curve (AUC) of all estimated CC chemokines were higher than those of CA 19-9. Interestingly, the obtained results also suggest CCL2's significance in the determination of local metastases and CCL4's significance in the determination of distant metastases. However, further studies concerning the role of selected CC chemokines in the course of colorectal cancer are necessary to confirm and to fully clarify their diagnostic utility and their clinical application as markers of CRC development.
结直肠癌(CRC)是最常被诊断出的肿瘤之一。尽管诊断工具和治疗方法有所进步,但CRC病例的数量仍在增加。因此,寻找可用于其诊断的新参数至关重要。因此,我们想评估所选CC趋化因子(CCL2、CCL4和CCL15)在CRC中的作用。该研究纳入了115名受试者(75名CRC患者和40名健康志愿者)。所有参数的血清浓度均采用多重检测方法(Luminex)进行测量。CRP水平通过免疫比浊法测定,经典肿瘤标志物(CEA和CA 19-9)采用化学发光微粒子免疫分析(CMIA)进行测量。与健康对照组相比,CRC组中所有参数的浓度均更高。所有评估的CC趋化因子的诊断敏感性、特异性、阳性和阴性预测值以及ROC曲线下面积(AUC)均高于CA 19-9。有趣的是,所得结果还表明CCL2在确定局部转移方面的重要性以及CCL4在确定远处转移方面的重要性。然而,有必要进一步研究所选CC趋化因子在结直肠癌病程中的作用,以确认并充分阐明它们作为CRC发展标志物的诊断效用及其临床应用。